الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

enping jiaxin daily necessities co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic, hand sanitizer hand sanitizer to help reduce bacteria that potentially can cause disease. for use when soap and water are not available. - in children less than 2 months of age - on open skin wounds stop use and ask a doctor if irritation or rash occurs. these may be signs of a serious condition.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

hangzhou huiji biotechnology co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - hand sanitizer to help reduce bacteria on the skin

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

ventura corporation limited - octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), oxybenzone (unii: 95oos7ve0y) (oxybenzone - unii:95oos7ve0y), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - octinoxate 0.075 g in 1 ml - - helps prevent sunburn. - higher spf gives more sunburn protection. - provides moderate protection against sunburn. - retains spf after 40 minutes of activity in the water.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

abbp (arrington, battle, bell & perry), llc - methyl salicylate (unii: lav5u5022y) (methyl salicylate - unii:lav5u5022y), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - methyl salicylate 30 ml in 100 ml - topical analgesic for the temporary relief of minor aches and pains of muscles and joints associated with simple backaches, arthritis, bruises, sprains and strains. - condition worsens - symptoms persist for more than seven (7) days - symptoms clear up and occur again within a few days.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

micro labs limited - losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - losartan potassium 25 mg - losartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood pressure. lowering blood pressure lowers the risk of fatal and nonfatal cardiovascular (cv) events, primarily strokes and myocardial infarction. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including losartan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

atlantis consumer healthcare, inc. - docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag), sennosides (unii: 3fyp5m0ijx) (sennosides - unii:3fyp5m0ijx) - docusate sodium 50 mg - uses - relieves occasional constipation (irregularity) - generally produces bowel movement in 6 to 12 hours warnings do not use - laxative products for longer than 1 week unless told to do so by a doctor - if you are presently taking mineral oil, unless told to do so by a doctor stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. these could be signs of a serious condition.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

welmedix llc - calendula officinalis tinc hpus, cantharis vesicatoria 3x hpus, echinacea angustifolia tinc hpus, the letters ‘hpus’ indicate that the active ingredients are officially monographed in the homeopathic pharmacopoeia of the united states. tinc and 3x are homeopathic dilutions: see www.firstdegree.com for details. - wound healing, superficial burns and scalds burns, scalds, rawness, burning pain itching, burning, irritation from insect bites temporarily relieves symptoms such as minor skin pain, rawness and itching due to: product uses are based on the homeopathic materia medica, and have not been evaluated by the food and drug administration.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

tec laboratories, inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 10 mg in 1 g

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

xi'an livingbond nonwoven products corp., ltd. - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - benzalkonium chloride 0.3 g in 100 g - for hand washing to decrease bacteria on the skin. may be used on face, arms and legs.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use: because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see warnings ], reserve hydrocodone bitartrate and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): - have not been tolerated or are not expected to be tolerated, - have not provided adequate analgesia or are not expected to provide adequate analgesia hydrocodone bitartrate and acetaminophen tablets should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate. hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with: •     significant respiratory depression [see warnings ] •     acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] •     known or suspected gastrointestinal obstruction, including paralytic ileus [see warnings ] •     hypersensitivity to hydrocodone or acetaminophen (e.g., anaphylaxis) [see warnings , adverse reactions ] controlled substance hydrocodone bitartrate and acetaminophen tablets contain hydrocodone, a schedule ii controlled substance. abuse hydrocodone bitartrate and acetaminophen tablets contains hydrocodone, a substance with high potential for misuse and abuse, which can lead to the development of substance use disorder, including addiction [see warnings ]. misuse is the intentional use, for therapeutic purposes, of a drug by an individual in a way other than prescribed by a healthcare provider or for whom it was not prescribed. abuse is the intentional non-therapeutic use of a drug, even once, for its desirable psychological or physiological effects. drug addiction is a cluster of behavioral, cognitive, and physiological phenomena that may include a strong desire to take the drug, difficulties in controlling drug use (e.g., continuing drug use despite harmful consequences, giving a higher priority to drug use than other activities and obligations), and possible tolerance or physical dependence. misuse and abuse of hydrocodone bitartrate and acetaminophen tablets increases risk of overdose, which may lead to central nervous system and respiratory depression, hypotension, seizures, and death. the risk is increased with concurrent abuse of hydrocodone bitartrate and acetaminophen tablets with alcohol and other cns depressants. abuse of and addiction to opioids in some individuals may not be accompanied by concurrent tolerance and symptoms of physical dependence. in addition, abuse of opioids can occur in the absence of addiction. all patients treated with opioids require careful and frequent reevaluation for signs of misuse, abuse, and addiction, because use of opioid analgesic products carries the risk of addiction even under appropriate medical use. patients at high risk of hydrocodone bitartrate and acetaminophen tablets abuse include those with a history of prolonged use of any opioid, including products containing hydrocodone, those with a history of drug or alcohol abuse, or those who use hydrocodone bitartrate and acetaminophen tablets in combination with other abused drugs. “drug-seeking” behavior is very common in persons with substance use disorders. drug-seeking tactics include emergency calls or visits near the end of office hours, refusal to undergo appropriate examination, testing, or referral, repeated “loss” of prescriptions, tampering with prescriptions, and reluctance to provide prior medical records or contact information for other treating healthcare provider(s). “doctor shopping” (visiting multiple prescribers to obtain additional prescriptions) is common among people who abuse drugs and people with substance use disorder. preoccupation with achieving adequate pain relief can be appropriate behavior in a patient with inadequate pain control. hydrocodone bitartrate and acetaminophen tablets, like other opioids, can be diverted for nonmedical use into illicit channels of distribution. careful record-keeping of prescribing information, including quantity, frequency, and renewal requests, as required by state and federal law, is strongly advised. proper assessment of the patient, proper prescribing practices, periodic reevaluation of therapy, and proper dispensing and storage are appropriate measures that help to limit abuse of opioid drugs. risks specific to abuse of hydrocodone bitartrate and acetaminophen tablets abuse of hydrocodone bitartrate and acetaminophen tablets poses a risk of overdose and death. the risk is increased with concurrent use of hydrocodone bitartrate and acetaminophen tablets with alcohol and/or other cns depressants. parenteral drug abuse is commonly associated with transmission of infectious diseases such as hepatitis and hiv. dependence: both tolerance and physical dependence can develop during use of opioid therapy. tolerance is a physiological state characterized by a reduced response to a drug after repeated administration (i.e., a higher dose of a drug is required to produce the same effect that was once obtained at a lower dose). physical dependence is a state that develops as a result of a physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dosage reduction of a drug. withdrawal may be precipitated through the administration of drugs with opioid antagonist activity (e.g., naloxone), mixed agonist/antagonist analgesics (e.g., pentazocine, butorphanol, nalbuphine), or partial agonists (e.g., buprenorphine). physical dependence may not occur to a clinically significant degree until after several days to weeks of continued use. do not abruptly discontinue hydrocodone bitartrate and acetaminophen tablets in a patient physically dependent on opioids. rapid tapering of hydrocodone bitartrate and acetaminophen tablets in a patient physically dependent on opioids may lead to serious withdrawal symptoms, uncontrolled pain, and suicide. rapid discontinuation has also been associated with attempts to find other sources of opioid analgesics, which may be confused with drug-seeking for abuse. when discontinuing hydrocodone bitartrate and acetaminophen tablets, gradually taper the dosage using a patient-specific plan that considers the following: the dose of hydrocodone bitartrate and acetaminophen tablets the patient has been taking, the duration of treatment, and the physical and psychological attributes of the patient. to improve the likelihood of a successful taper and minimize withdrawal symptoms, it is important that the opioid tapering schedule is agreed upon by the patient. in patients taking opioids for an extended period of time at high doses, ensure that a multimodal approach to pain management, including mental health support (if needed), is in place prior to initiating an opioid analgesic taper [see dosage and administration, warnings ]. infants born to mothers physically dependent on opioids will also be physically dependent and may exhibit respiratory difficulties and withdrawal signs [see precautions; pregnancy ].